LBRX

LB Pharmaceuticals
LBRX

Upgrade to unlock
Buy
Hold
Sell

3 Wall Street Analysts provided 1 year price targets over the past 3 months

Low target
Avg. target
$49
157% upside
High target

3 analyst ratings

positive
0  neutral
0%
negative
Analyst & Firm Rating Price Target Upside
Downside 		Date
Stifel
Stifel
Paul Matteis
50% 1-yr LBRX win rate
11 Dec ‘25 7 days ago
Piper Sandler
Piper Sandler
Yasmeen Rahimi
100% 1-yr LBRX win rate
6 Oct ‘25 2 months ago
Leerink Partners
Leerink Partners
Marc Goodman
100% 1-yr LBRX win rate
6 Oct ‘25 2 months ago